Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
apM Members Signs Supply Agreement for apM e-Voucher with Global FX Total Solution Provider SentBe
-
Shake Shack Announces Fourth Quarter and Fiscal Year 2025 Financial Results
-
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
-
Budget sets out strategies to propel Hong Kong’s innovation and technology development
-
Upbound Group, Inc. to Participate in the 2026 Raymond James Institutional Investors Conference
-
BlackSky Reports Fourth Quarter and Full Year 2025 Results
-
Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
-
Olezarsen sNDA accepted by the FDA for Priority Review for the treatment of severe hypertriglyceridemia (sHTG)
-
After a Breakout Year, SilverChef USA Ramps up Nationwide Expansion to Bring Flexible Financing to More Hospitality Operators
-
Palmer Square Capital BDC Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
-
DORITOS® LAUNCHES BOLDEST INNOVATION YET: DORITOS PROTEIN
-
Varicent Appoints Former Workday Co-President Doug Robinson to Board as It Redefines How Revenue Teams Operate At Scale
-
Alterome Therapeutics to Participate in Upcoming Investor Conferences
-
Good Supply Cannabis Brand Expands High-Potency Portfolio with New Spring Lineup Across Canada
-
TIC Solutions Confirms Date for Fourth Quarter and Full Year 2025 Earnings Release and Announces Participation in Upcoming Investor Conferences
-
ACM Research Reports Fourth Quarter and Fiscal Year 2025 Results
-
Toberman Becker Wealth Announces New Team Member: Mike Holtz, CFP®
-
ACM Research Receives Multiple Advanced Packaging Equipment Orders from Leading Global Customers
-
ACM Research Delivers Multiple Single-Wafer Cleaning Systems to Foundry Customer in Singapore
-
Luckin Coffee Announces Fourth Quarter and Fiscal Year 2025 Financial Results
-
AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder
-
GigaCloud Technology Inc Announces Fourth Quarter and Year Ended December 31, 2025 Financial Results
-
Cotality Appoints Former USAA CEO Wayne Peacock to Board
-
Tecnoglass Reports Fourth Quarter and Full Year 2025 Results
-
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03
-
Kyivstar Group Board Members Visit Ukraine on the Fourth Anniversary of the Full-Scale War
-
Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight Maintenance
-
Macerich to Present at Citi’s 2026 31st Annual Global Property CEO Conference
-
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
-
Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026
-
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
-
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
Calian and ADGA Group Sign Collaborative Agreement to Advance Next-Generation Land Training and Simulation for the Canadian Army
-
C4 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
-
PyroGenesis Confirms Successful Primary Test Campaign with Leading Battery Recycler
-
Aeluma to Participate in 38th Annual ROTH Conference
-
Aikido Security Introduces Aikido Infinite, Delivering the Industry’s First Self-Securing Software Solution
-
Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
-
Shenandoah Telecommunications Company Reports Fourth Quarter and Full Year 2025 Results
-
FactSet Schedules Second Quarter 2026 Earnings Call
-
Amphista Therapeutics presents new data demonstrating how its advanced Eclipsys® platform is delivering Targeted Glue™ degraders using novel E3 ligases into the clinic
-
Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics
-
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results
-
Rocky Shore Gold Closes Final Tranche of Oversubscribed Non-Brokered Private Placement
-
U.S. Polo Assn. Returns as Official Apparel and Jersey Sponsor of the 2026 Dubai Polo Gold Cup for Third Consecutive Year
-
Southwest Pet Earns 2026 Consumer Choice Award Recognition as a Trusted Destination for Pet Care in London
-
Larlyn Property Management Ltd. Recognized with 2026 Consumer Choice Award in London
-
Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership
-
Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results
-
Isocyanate Market worth $39.68 billion by 2030 - Exclusive Report by MarketsandMarkets™
